Leigh L. Oliver

Leigh L. Oliver

Partner
Washington, D.C.

Email [email protected]​hoganlovells.com

Phone +1 202 637 3648

Fax +1 202 637 5910

Practice groupGlobal Regulatory

She is extraordinarily attentive to detail and to strategy, an excellent team leader and very responsive to client needs.

Chambers USA 2022

From strategic transactions to government investigations, Leigh Oliver helps companies step through their most difficult antitrust issues. She represents clients before both state and federal antitrust enforcers on matters such as domestic and multijurisdictional mergers, joint ventures, and competitor collaborations.

Leigh is known in the antitrust bar for working with clients in some of the most heavily scrutinized industries, including health care, life sciences, and aerospace and defense. Her tireless work ethic and ability to build relationships with witnesses and clients to gain in-depth understanding of competitive market dynamics creates the formula for a winning strategy. Leigh was named "Lawyer of the Year – Under 40" by Global Competition Review (GCR) in 2017 and a Mergers & Acquisitions (M&A) and Antitrust Trailblazer by the National Law Journal for her work in 2016.

She has played a critical role in successfully defending companies in FTC merger investigations and challenges, including: Einstein Health Network’s merger with Thomas Jefferson University, Advocate Health Care’s merger with NorthShore University HealthSystem, and LabCorp v. FTC, which was named the 2011 "Litigation of the Year" by GCR.

Awards and recognitions

2021

Antitrust (District of Columbia)
Chambers USA

2019-2021

Healthcare: Advice to Service Providers, Next Generation Partner
Legal 500 US

2017-2021

Competition: Future Leaders, Most Highly Regarded
Who's Who Legal

2021

Healthcare: Global Leader
Who's Who Legal

2019

40 in their 40s: Notable Women Competition Professionals in Americas
[email protected]

2017-2019

Antitrust: Merger Control
Legal 500 US

2017

Lawyer of the Year - Under 40
Global Competition Review (GCR)

2017

Competition
Who's Who Legal

2016

Merger & Acquisitions (M&A) and Antitrust Trailblazer
National Law Journal

2015

Rising Star: Corporate, U.S. Northeast, U.S. South
Euromoney Legal Media Group's Americas Women in Business Law Awards

2009

Outstanding Healthcare Antitrust Lawyer
Nightingale's Health Care News

Education and admissions

Education

J.D., The Catholic University of America, Columbus School of Law, magna cum laude, 2004

B.A., Haverford College, 2000

Memberships

Co-Chair, ABA Antitrust Section Committee Operations

Member, American Bar Association (ABA)

Member, American Health Lawyers Association (AHLA)

Bar admissions and qualifications

District of Columbia

Maryland

Representative experience

Represented Einstein Health Network in successful defense of its merger with Thomas Jefferson University from preliminary injunction challenge by the FTC.

Represented Aspirus, Inc. in its acquisition of Ascension facilities in central, northern Wisconsin.

Represented Penn State Health in its acquisition of Geisinger’s Holy Spirit Hospital.

Represented Atrium Health and Wake Forest Baptist Medical Center in their combination.

Represented UW Health and UnityPoint Health in their proposed combination of healthcare provider and insurer services in Wisconsin.

Represented Advocate HealthCare in litigating the defense of its 2016 proposed merger with NorthShore University HealthSystem.

Counsel to LabCorp in various transactions in the drug development and diagnostics areas, including successful defense of its challenged merger with Westcliff Medical Laboratories.

Represented Lahey Health and Winchester Hospital in a combination that was reviewed by the Massachusetts Health Policy Commission.

Antitrust counsel to PPG Industries, Inc. in various transactions, including the acquisition of Akzo Nobel's architectural coatings business.

Represented GenCorp-Aerojet in its acquisition of Pratt & Whitney Rocketdyne, a transaction that was opposed by the FTC.

Antitrust counsel to Orbital Sciences in its acquisition of ATK.

Loading data